Table 3 Association between SCFD2 status and clinicopathological parameters in 114 breast cancer.

From: PSPC1 is a potential prognostic marker for hormone-dependent breast cancer patients and modulates RNA processing of ESR1 and SCFD2

Status

SCFD2 status

P value

Weak (n = 69)

Strong (n = 45)

Age (year)a

51.8 ± 10.4

54.5 ± 11.9

0.20

Body weight (kg)a

55.0 ± 7.9

53.3 ± 8.8

0.28

BMIa

21.9 ± 3.6

21.9 ± 2.9

0.94

Stage

I

37

21

 

II

30

20

 

III

2

4

0.35

Pathological T factor (pT)

pT1

42

30

 

pT2–4

27

15

0.53

Pathological N factor (pN)

pN0–1

55

32

 

pN2–3

14

13

0.29

Histological grade

1–2

64

35

 

3

5

10

0.021

Lymphovascular infiltration (LVI)

Negative

43

20

 

Positive

26

25

0.061

ER labeling index (%)a

68.7 ± 25.4

71.3 ± 26.1

0.59

PR status

Negative

10

8

 

Positive

59

37

0.64

HER2 status

Negative

65

36

 

Positive

4

9

0.021

PSF status

Weak

42

15

 

Strong

27

30

0.0041

PSPC1 status

Weak

55

29

 

Strong

14

16

0.070

  1. P value < 0.05 and 0.05 ≤ P value < 0.10 were considered significant and borderline significant, and were listed in bold and italic, respectively.
  2. aData are presented as mean ± SD. All other values represent the number of cases.
Back to article page